香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 聯合醫務集團有限公司 公司秘書 茲提述聯合醫務集團有限公司（「本公司」日期為2025年10月9日有關（其中包括） 2026年周大福人壽醫療服務協議之持續關連交易之公告（「該公告」）。除另有界定 者外，本公告所用詞彙與該公告所界定者具有相同涵義。 本公司董事（「董事」）會（「董事會」）謹此宣佈，本公司擬於2025年11月21日（星期五） 舉行股東特別大會。為釐定有權出席股東特別大會並於會上投票的本公司股東（「股 東」）名單，本公司將於2025年11月18日（星期二）至2025年11月21日（星期五）（包括 首尾兩日）暫停辦理股份過戶登記手續，期間將不會辦理本公司股份過戶登記。 為符合資格出席股東特別大會並於會上投票，所有股份過戶表格連同相關股票須 不遲於2025年11月17日（星期一）下午四時三十分送交本公司之香港股份過戶登記 分處卓佳證券登記有限公司（地址為香港夏愨道16號遠東金融中心17樓），以作登記 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 聯合醫務集團有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00722 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.001 | HKD | | 5,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.001 | HKD | | 5,000,000 | 本月底法 ...

(Stock Code: 722) 荵嚎⋚⊿屽莇722荶 NOTIFICATION LETTER 通知信函 Dear Non-registered Holder(s) (Note 1), 28 October 2025 UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ (Incorporated in the Cayman Islands with limited liability) 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 UMP HEALTHCARE HOLDINGS LIMITED (the "Company") – Notification of publication of Annual Report 2025, Circular and Notice of Annual General Meeting (collectively the "Current Corporate Communication(s)") The English and Chinese versions of the Company's Current Corporate Communica ...

UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ (Incorporated in the Cayman Islands with limited liability) 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 (Stock Code: 722) 荵嚎⋚⊿屽莇722荶 NOTIFICATION LETTER 通知信函 Dear Registered Shareholders, 28 October 2025 UMP HEALTHCARE HOLDINGS LIMITED (the "Company") – Notice of publication of Annual Report 2025, Circular, Notice of Annual General Meeting and Proxy Form (collectively the "Current Corporate Communication(s)") If you have difficulty in receiving email notification or gaining access to the W ...

UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 荵嚎⋚⊿屽莇722荶 於2025年11月21日（星期五）舉行的股東週年大會的代表委任表格 請於適當空欄加上「✔」號以示 閣下的投票意願 （附註4） 。 | | 普通決議案 | 贊成 | 反對 | | --- | --- | --- | --- | | 1. | 省覽及採納本公司及其附屬公司截至2025年6月30日止年度的經審核綜合財務報表及董事會報告及 | | | | | 核數師報告。 | | | | 2. | 宣派截至2025年6月30日止年度末期股息每股1.90港仙。 | | | | 3(a). | 重選孫耀江醫生為本公司執行董事。 | | | | 3(b). | 重選孫文堅醫生為本公司執行董事。 | | | | 3(c). | 重選郭卓君女士為本公司執行董事。 | | | | 3(d). | 授權本公司董事會釐定相關董事的薪酬。 | | | | 4. | 續聘畢馬威會計師事務所為本公司的核數師，並授權本公司董事會釐定其薪酬。 | | | | 5. | 向本公司董事授出一般授權，以購 ...

閣下如已將名下的聯合醫務集團有限公司股份全部售出或轉讓，應立即將本通函連 同隨附的代表委任表格送交買主或承讓人或經手出售或轉讓的銀行、股票經紀或其 他代理商，以便轉交買主或承讓人。 香港交易及結算所有限公司與香港聯合交易所有限公司對本通函的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通函全部或任何 部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 荵嚎⋚⊿屽莇722荶 建議 此乃要件 請即處理 閣下如對本通函的任何方面或應採取的行動有任何疑問，應諮詢股票經紀或其他註 冊證券商、銀行經理、律師、專業會計師或其他專業顧問。 (1) 重選退任董事； (2) 授出關於購回股份及發行股份的一般授權； (3) 續聘核數師； 及 股東週年大會通告 聯合醫務集團有限公司謹訂於2025年11月21日（星期五）下午2時30分假座香港德輔道 中71號永安集團大廈14樓舉行股東週年大會，召開大會的通告載於本通函第15至19頁。 隨函同時附上股東週年大會所用之代表委任表格 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 荵嚎⋚⊿屽莇722荶 股東週年大會通告 茲通告聯合醫務集團有限公司（「本公司」）謹訂於2025年11月21日（星期五）下午2時 30分假座香港德輔道中71號永安集團大廈14樓舉行股東週年大會，以考慮下列事宜： 1 1. 省覽及採納本公司及其附屬公司截至2025年6月30日止年度的經審核綜合 財務報表及董事會報告及核數師報告。 2. 宣派截至2025年6月30日止年度末期股息每股本公司股份1.90港仙。 3. (a) 重選孫耀江醫生為本公司執行董事。 (b) 重選孫文堅醫生為本公司執行董事。 (c) 重選郭卓君女士為本公司執行董事。 (d) 授權本公司董事會釐定相關董事的薪酬。 4. 續聘畢馬威會計師事務所為本公司的核數師，並授權本公司董事會釐定其薪酬。 5. 考慮及酌情通過（無論有 ...

Financial Performance - Revenue for the year ended June 30, 2025, was HK$726,949,000, a decrease of 2.9% from HK$748,489,000 in 2024[10] - EBITDA increased by 2.7% to HK$87,025,000 from HK$84,776,000, reflecting improved operational efficiency[10] - Adjusted EBITDA rose significantly by 21.1% to HK$94,878,000 compared to HK$78,357,000 in the previous year[10] - Profit for the year decreased by 9.4% to HK$31,916,000 from HK$35,217,000 in 2024[10] - Profit attributable to owners of the Company fell by 22.6% to HK$31,440,000 from HK$40,643,000[10] - Basic and diluted earnings per share decreased by 21.7% to HK$3.98 from HK$5.08[10] - Proposed final dividend per share is HK$1.90, down 5.0% from HK$2.00 in the previous year[10] - Interim dividend per share increased by 7.7% to HK$1.40 from HK$1.30[10] - The Company reported a profit before tax of HK$40,499,000, a slight decrease of 0.3% from HK$40,624,000[10] - For the fiscal year 2025, the EBITDA margin increased to 12.0%, up by 0.7 percentage points from 11.3% in 2024[12] - Adjusted EBITDA margin improved to 13.1%, reflecting a significant increase of 2.6 percentage points compared to 10.5% in the previous year[12] - Net profit margin decreased to 4.4%, down by 0.3 percentage points from 4.7% in 2024[12] Assets and Liabilities - Total assets as of June 30, 2025, were HK$1,095,325, a decrease of 1.0% from HK$1,106,823 in 2024[12] - Cash, bank balances, and deposits increased by 18.2% to HK$302,836 from HK$256,139 in 2024[12] - Net current assets rose by 22.4% to HK$267,681, compared to HK$218,719 in the previous year[12] - Shareholders' funds increased by 2.3% to HK$742,632 from HK$725,942 in 2024[12] - Right-of-use assets as of June 30, 2025, were approximately HK$96.5 million, down from HK$107.2 million in FY2024, representing about 8.8% of the Group's total assets[191][195] - Goodwill as of June 30, 2025, was approximately HK$156.6 million, a decrease from HK$164.2 million in FY2024, representing about 14.7% of the Group's total assets[193][196] - Investments at fair value through other comprehensive income amounted to approximately HK$40.3 million as of June 30, 2025, an increase from HK$30.5 million in FY2024[199] - Financial assets at fair value through profit or loss were approximately HK$38.9 million as of June 30, 2025, a decrease from HK$41.1 million in FY2024[199] - The total value of investments at fair value through other comprehensive income and financial assets at fair value through profit or loss represented about 7.2% of the Group's total assets as of June 30, 2025, compared to 6.5% in FY2024[199] Strategic Initiatives - The company announced the establishment of a new community medical healthcare center in Guangdong Province as part of its Greater Bay Area strategy[22] - Investments in smart clinic systems and AI-assisted diagnostics are aimed at enhancing operational efficiency and supporting proactive health management[22] - The focus on preventive medicine includes health screenings and wellness initiatives, aiming to attract more patients and strengthen revenue streams[22] - The corporate healthcare solutions business now serves over 1.3 million end users across more than 1,000 service points in Hong Kong, Macau, and Chinese Mainland[31] - The company continues to strengthen its third-party administration (TPA) services to provide a more comprehensive and integrated healthcare service[37] - The company is tailoring corporate healthcare plans to enrich employee benefits while balancing cost budgets for related companies[39] - The company is focused on ensuring that every patient interaction is supported by the best that modern medicine can offer[42] - The Corporate Solutions and Managed Care division remains a robust core of the business, leveraging data analytics to enhance client relationships and achieve high retention rates[46] - A new Clinic Management System (CMS) was launched, achieving a fully paperless workflow across outpatient centers, alongside the Electronic Pre-Approval (EPA) platform for seamless integration[47] - The establishment of a new TPA office and a Hong Kong-invested health station in Foshan marks a significant step in expanding regional footprint and service capabilities[48] - The company is actively exploring strategic partnerships and M&A opportunities across the Greater Bay Area and other regions in Chinese Mainland[48] - UMP aims to create a seamless, patient-centric journey across all service lines while investing in the next generation of clinical and managerial leaders[54] - The company is committed to evolving service models to meet changing market needs and strengthening its impact across the Greater Bay Area and beyond[54] Market Challenges and Responses - The company faced a challenging macroeconomic environment, impacting corporate decision-making and operational priorities[77] - The demand for Immigration Medical Examination (IME) services significantly declined due to economic downturn and geopolitical tensions in 2025[135][140] - The full reopening of borders between Hong Kong and Mainland China is expected to unleash pent-up demand for high-quality medical services[99] - The company is increasing its focus on the small and medium enterprise sector, which has shown resilient growth and a strong appetite for structured benefits packages[100] - The extensive and curated network of premium healthcare providers in Hong Kong serves as a critical competitive advantage for the company[101] - The company is engaging existing clients to enhance their plans for remaining employees, thereby maintaining per-member revenue[100] - Revenue in Hong Kong and Macau clinical healthcare services decreased by 4.3%, while operating profit increased by 16.4% due to lower costs[111] - Strategic focus for FY2025 on operational excellence and cost optimization, leading to stable and profitable growth[112] Growth and Development - The company achieved high-single-digit revenue growth, primarily driven by increased utilization of comprehensive healthcare plans and a surge in demand for related clinical medical services[88] - Profit margins expanded due to operational efficiencies and the scalable nature of the TPA platform, showcasing the strategic value of the integrated model[88] - The company focused on building a one-stop healthcare ecosystem by expanding partnerships beyond core insurance providers to include wellness tech firms and pharmaceutical providers[94] - A significant increase in the utilization of insured healthcare plans was observed, reflecting a shift towards quality and security during uncertain times[87] - The company successfully launched enhanced and modular plan options, allowing clients to enrich employee benefits while controlling costs[83] - The restructuring and integration of medical imaging and testing centers began to show results in FY2025, contributing significantly to revenue and profit growth[66] - The newly established medical imaging centres contributed positively to revenue growth, indicating a key growth vector for the future[75] - The company is focused on digital transformation, including launching a comprehensive member mobile app for easier access to services and personalized health tracking[161] - Future strategies include exploring geographic expansion in the Asia-Pacific region and introducing new service lines such as advanced mental health programs[162] - Continued investment in partnerships, technology, and regional expansion is identified as key pillars for growth and sustainability[163]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 UMP HEALTHCARE HOLDINGS LIMITED 噛⠡桂⛪涐⭒㯡洒軴⠑ 荵㪇 汇㯒啯ㅤ躳▌踁偽逓㯡洒軴 ⠑荶 荵嚎⋚⊿屽莇722荶 補充公告 有關醫療服務框架協議的 持續關連交易 及 有關附屬公司層面醫療服務的 歷史持續關連交易 謹此提述聯合醫務集團有限公司（「本公司」）日期為2025年7月31日的公告（「該公 告」），內容有關（其中包括）協議連同其項下擬進行的交易構成本公司的持續關連 交易。 本公司謹此就(i)協議；及(ii)有關仁德醫療相關服務及聯合醫務醫療相關服務的歷 史交易提供進一步資料。 除本公告另有指明外，本公告所用詞彙與該公告所界定者具有相同涵義。 協議 仁德醫療相關服務及聯合醫務醫療相關服務的服務範疇 仁德醫療相關服務主要包括由仁德醫健集團聘用的專科醫生及外科專科醫生所提 供的醫療服務，而聯合醫務醫療相關服務則主要包括向仁德醫健集團提供化驗及 影像服務等輔助醫療服務及由全科 ...

Core Viewpoint - The company has entered into a medical service agreement with Chow Tai Fook Life Insurance, which will enhance its service offerings and potentially increase revenue streams [1] Group 1: Agreement Details - The agreement is set to commence on January 1, 2026, and will last for two and a half years [1] - The agreement involves the provision and management of medical services to members and/or family members of Chow Tai Fook Life Insurance [1] Group 2: Company Structure - The agreement is established through the company's indirect wholly-owned subsidiary, United Medical Professional [1]